|
1
|
Radenkovic S, Konjevic G, Isakovic A,
Stevanovic P, Gopcevic K and Jurisic V: HER2-positive breast cancer
patients: Correlation between mammographic and pathological
findings. Radiat Prot Dosimetry. 162:125–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tao Z, Shi A, Lu C, Song T, Zhang Z and
Zhao J: Breast cancer: Epidemiology and etiology. Cell Biochem
Biophys. 72:333–338. 2015. View Article : Google Scholar
|
|
4
|
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z,
Zhang L, Ji X, Liu W, Huang B, Luo W, et al: Breast cancer
development and progression: Risk factors, cancer stem cells,
signaling pathways, genomics, and molecular pathogenesis. Genes
Dis. 5:77–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Radenkovic S, Konjevic G, Gavrilovic D,
Stojanovic-Rundic S, Plesinac-Karapandzic V, Stevanovic P and
Jurisic V: pSTAT3 expression associated with survival and
mammographic density of breast cancer patients. Pathol Res Pract.
215:366–372. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen F, Han B, Meng Y, Han Y, Liu B, Zhang
B, Chang Y, Cao P, Fan Y and Tan K: Ceruloplasmin correlates with
immune infiltration and serves as a prognostic biomarker in breast
cancer. Aging (Albany NY). 13:20438–20467. 2021. View Article : Google Scholar
|
|
7
|
Lee SY, Ju MK, Jeon HM, Jeong EK, Lee YJ,
Kim CH, Park HG, Han SI and Kang HS: Regulation of tumor
progression by programmed necrosis. Oxid Med Cell Longev.
2018:35374712018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seibt TM, Proneth B and Conrad M: Role of
GPX4 in ferroptosis and its pharmacological implication. Free Radic
Biol Med. 133:144–152. 2019. View Article : Google Scholar
|
|
10
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
CISD1 inhibits ferroptosis by protection against mitochondrial
lipid peroxidation. Biochem Biophys Res Commun. 478:838–844. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ooko E, Saeed ME, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu ZH, Tang Y, Yu H and Li HD: The role of
ferroptosis in breast cancer patients: A comprehensive analysis.
Cell Death Discov. 7:932021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang D, Wei G, Ma J, Cheng S, Jia L, Song
X, Zhang M, Ju M, Wang L, Zhao L, et al: Identification of the
prognostic value of ferroptosis-related gene signature in breast
cancer patients. BMC Cancer. 21:6452021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sato M, Kusumi R, Hamashima S, Kobayashi
S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S and Sato
H: The ferroptosis inducer erastin irreversibly inhibits system xc-
and synergizes with cisplatin to increase cisplatin's cytotoxicity
in cancer cells. Sci Rep. 8:9682018. View Article : Google Scholar
|
|
16
|
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C,
Dai X, Li Z and Wu G: Ferroptosis: A novel anti-tumor action for
cisplatin. Cancer Res Treat. 50:445–460. 2018. View Article : Google Scholar :
|
|
17
|
Li Z, Chen L, Chen C, Zhou Y, Hu D, Yang
J, Chen Y, Zhuo W, Mao M, Zhang X, et al: Targeting ferroptosis in
breast cancer. Biomark Res. 8:582020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie Y, Xiao Y, Liu Y, Lu X, Wang Z, Sun S,
Liu L, Tang X, Xiao H and Liu H: Construction of a novel
radiosensitivity- and ferroptosis-associated gene signature for
prognosis prediction in gliomas. J Cancer. 13:2683–2693. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yue Z, Sun J and Shi L: Construction and
validation of a 6-Ferroptosis related gene signature for prognosis
and immune landscape prediction in melanoma. Front Genet.
13:8875422022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xing XL, Liu Y, Liu J, Zhou H, Zhang H,
Zuo Q, Bu P, Duan T, Zhou Y and Xiao Z: Comprehensive analysis of
ferroptosis- and immune-related signatures to improve the prognosis
and diagnosis of kidney renal clear cell carcinoma. Front Immunol.
13:8513122022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sui S, Xu S and Pang D: Emerging role of
ferroptosis in breast cancer: New dawn for overcoming tumor
progression. Pharmacol Ther. 232:1079922022. View Article : Google Scholar
|
|
22
|
Wu M, Zhang X, Zhang W, Chiou YS, Qian W,
Liu X, Zhang M, Yan H, Li S, Li T, et al: Cancer stem cell
regulated phenotypic plasticity protects metastasized cancer cells
from ferroptosis. Nat Commun. 13:13712022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Konjevic GM, Vuletić AM, Mirjacic
Martinovic KM, Larsen AK and Jurisic VB: The role of cytokines in
the regulation of NK cells in the tumor environment. Cytokine.
117:30–40. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jurisic V: Multiomic analysis of cytokines
in immuno-oncology. Expert Rev Proteomics. 17:663–674. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ni S, Yuan Y, Kuang Y and Li X: Iron
metabolism and immune regulation. Front Immunol. 13:8162822022.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ganz T and Nemeth E: Iron homeostasis in
host defence and inflammation. Nat Rev Immunol. 15:500–510. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Green M, Choi JE, Gijon M, Kennedy
PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al:
CD8+ T cells regulate tumour ferroptosis during cancer
immunotherapy. Nature. 569:270–274. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kao KJ, Chang KM, Hsu HC and Huang AT:
Correlation of microarray-based breast cancer molecular subtypes
and clinical outcomes: Implications for treatment optimization. BMC
Cancer. 11:1432011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature. 486:346–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu Q, Tang X, Zhu W, Li Q, Zhang X and Li
H: The potential prognostic role of oligosaccharide-binding
fold-containing protein 2A (OBFC2A) in triple-negative breast
cancer. Front Oncol. 11:7514302021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuo S, Chen Z, Yang Y, Zhang J, Tang J
and Yang K: Clinical and biological significances of a
ferroptosis-related gene signature in glioma. Front Oncol.
10:5908612020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang R, Hua J, Xu J, Liang C, Meng Q, Liu
J, Zhang B, Yu X and Shi S: The role of ferroptosis regulators in
the prognosis, immune activity and gemcitabine resistance of
pancreatic cancer. Ann Transl Med. 8:13472020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
R Core Team: 2012, R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna, Austria: ISBN: 3-900051-07-0URL http://www.R-project.org/.
|
|
34
|
Gaujoux R and Seoighe C: A flexible R
package for nonnegative matrix factorization. BMC Bioinformatics.
11:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Brunet JP, Tamayo P, Golub TR and Mesirov
JP: Metagenes and molecular pattern discovery using matrix
factorization. Proc Natl Acad Sci USA. 101:4164–4169. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Friedman J, Hastie T and Tibshirani R:
Regularization paths for generalized linear models via coordinate
descent. J Stat Softw. 33:1–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoshihara K, Shahmoradgoli M, Martinez E,
Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Becht E, Giraldo NA, Lacroix L, Buttard B,
Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautes-Fridman
C, Fridman WH, et al: Estimating the population abundance of
tissue-infiltrating immune and stromal cell populations using gene
expression. Genome Biol. 17:2182016. View Article : Google Scholar
|
|
39
|
Rooney MS, Shukla SA, Wu CJ, Getz G and
Hacohen N: Molecular and genetic properties of tumors associated
with local immune cytolytic activity. Cell. 160:48–61. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roh W, Chen PL, Reuben A, Spencer CN,
Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy
SM, et al: Integrated molecular analysis of tumor biopsies on
sequential CTLA-4 and PD-1 blockade reveals markers of response and
resistance. Sci Transl Med. 9:eaah35602017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Reinhold WC, Sunshine M, Liu H, Varma S,
Kohn KW, Morris J, Doroshow J and Pommier Y: CellMiner: A web-based
suite of genomic and pharmacologic tools to explore transcript and
drug patterns in the NCI-60 cell line set. Cancer Res.
72:3499–3511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vickers AJ, Cronin AM, Elkin EB and Gonen
M: Extensions to decision curve analysis, a novel method for
evaluating diagnostic tests, prediction models and molecular
markers. BMC Med Inform Decis Mak. 8:532008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Michielin O, Lalani AK, Robert C, Sharma P
and Peters S: Defining unique clinical hallmarks for immune
checkpoint inhibitor-based therapies. J Immunother Cancer.
10:e0030242022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hubert P, Roncarati P, Demoulin S, Pilard
C, Ancion M, Reynders C, Lerho T, Bruyere D, Lebeau A, Radermecker
C, et al: Extracellular HMGB1 blockade inhibits tumor growth
through profoundly remodeling immune microenvironment and enhances
checkpoint inhibitor-based immunotherapy. J Immunother Cancer.
9:e0019662021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang C, Huang X, Liu Z, Qin W and Wang C:
Metabolism-associated molecular classification of hepatocellular
carcinoma. Mol Oncol. 14:896–913. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu
N, Shi Y, Chen L, Xiao D, Yu F, et al: Long noncoding RNA LINC00336
inhibits ferroptosis in lung cancer by functioning as a competing
endogenous RNA. Cell Death Differ. 26:2329–2343. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gai C, Yu M, Li Z, Wang Y, Ding D, Zheng
J, Lv S, Zhang W and Li W: Acetaminophen sensitizing
erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1
signaling pathway in non-small-cell lung cancer. J Cell Physiol.
235:3329–3339. 2020. View Article : Google Scholar
|
|
49
|
Cui Z, Fu Y, Yang Z, Gao Z, Feng H, Zhou
M, Zhang L and Chen C: Comprehensive analysis of a ferroptosis
pattern and associated prognostic signature in acute myeloid
leukemia. Front Pharmacol. 13:8663252022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Y, Yang J, Chen S, Wang W and Teng L:
Identification and validation of a prognostic signature for thyroid
cancer based on ferroptosis-related genes. Genes (Basel).
13:9972022. View Article : Google Scholar
|
|
51
|
Fan R, Chen Y, Nechuta S, Cai H, Gu K, Shi
L, Bao P, Shyr Y, Shu XO and Ye F: Prediction models for breast
cancer prognosis among Asian women. Cancer. 127:1758–1769. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang YF, Lee YC, Wang YY, Wang CH, Hou MF
and Yuan SF: YWHAE promotes proliferation, metastasis, and
chemoresistance in breast cancer cells. Kaohsiung J Med Sci.
35:408–416. 2019.PubMed/NCBI
|
|
53
|
Liu T, Jiang L, Tavana O and Gu W: The
Deubiquitylase OTUB1 mediates ferroptosis via stabilization of
SLC7A11. Cancer Res. 79:1913–1924. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zou Y, Palte MJ, Deik AA, Li H, Eaton JK,
Wang W, Tseng YY, Deasy R, Kost-Alimova M, Dančík V, et al: A
GPX4-dependent cancer cell state underlies the clear-cell
morphology and confers sensitivity to ferroptosis. Nat Commun.
10:16172019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lang X, Green MD, Wang W, Yu J, Choi JE,
Jiang L, Liao P, Zhou J, Zhang Q, Dow A, et al: Radiotherapy and
immunotherapy promote tumoral lipid oxidation and ferroptosis via
synergistic repression of SLC7A11. Cancer Discov. 9:1673–1685.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lee YH, Kim HS, Kim JS, Yu MK, Cho SD,
Jeon JG and Yi HK: C-myb regulates autophagy for pulp vitality in
glucose oxidative stress. J Dent Res. 95:430–438. 2016. View Article : Google Scholar
|
|
57
|
Minekura H, Kang MJ, Inagaki Y, Suzuki H,
Sato H, Fujino T and Yamamoto TT: Genomic organization and
transcription units of the human acyl-CoA synthetase 3 gene. Gene.
278:185–192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hao S, Yu J, He W, Huang Q, Zhao Y, Liang
B, Zhang S, Wen Z, Dong S, Rao J, et al: Cysteine dioxygenase 1
mediates erastin-induced ferroptosis in human gastric cancer cells.
Neoplasia. 19:1022–1032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Alfarsi LH, El Ansari R, Masisi BK, Parks
R, Mohammed OJ, Ellis IO, Rakha EA and Green AR: Integrated
analysis of key differentially expressed genes identifies DBN1 as a
predictive marker of response to endocrine therapy in luminal
breast cancer. Cancers (Basel). 12:15492020. View Article : Google Scholar
|
|
60
|
Wang X, Fu Y, Chen X, Ye J, Lü B, Ye F, Lü
W and Xie X: The expressions of bHLH gene HES1 and HES5 in advanced
ovarian serous adenocarcinomas and their prognostic significance: A
retrospective clinical study. J Cancer Res Clin Oncol. 136:989–996.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Konishi J, Kawaguchi KS, Vo H, Haruki N,
Gonzalez A, Carbone DP and Dang TP: Gamma-secretase inhibitor
prevents Notch3 activation and reduces proliferation in human lung
cancers. Cancer Res. 67:8051–8057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li X, Cao Y, Li M and Jin F: Upregulation
of HES1 promotes cell proliferation and invasion in breast cancer
as a prognosis marker and therapy target via the AKT pathway and
emt process. J Cancer. 9:757–766. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li X, Li Y, Du X, Wang X, Guan S, Cao Y,
Jin F and Li F: HES1 promotes breast cancer stem cells by elevating
slug in triple-negative breast cancer. Int J Biol Sci. 17:247–258.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X,
Wang H, Cao L and Tang D: HSPB1 as a novel regulator of ferroptotic
cancer cell death. Oncogene. 34:5617–5625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Jiang XP, Elliott RL and Head JF:
Manipulation of iron transporter genes results in the suppression
of human and mouse mammary adenocarcinomas. Anticancer Res.
30:759–765. 2010.PubMed/NCBI
|
|
66
|
Emens LA: Breast cancer immunotherapy:
Facts and hopes. Clin Cancer Res. 24:511–520. 2018. View Article : Google Scholar :
|
|
67
|
Dunn GP, Bruce AT, Ikeda H, Old LJ and
Schreiber RD: Cancer immunoediting: From immunosurveillance to
tumor escape. Nat Immunol. 3:991–998. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jia M, Qin D, Zhao C, Chai L, Yu Z, Wang
W, Tong L, Lv L, Wang Y, Rehwinkel J, et al: Redox homeostasis
maintained by GPX4 facilitates STING activation. Nat Immunol.
21:727–735. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Maldonado EN and Lemasters JJ: Warburg
revisited: Regulation of mitochondrial metabolism by
voltage-dependent anion channels in cancer cells. J Pharmacol Exp
Ther. 342:637–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yagoda N, von Rechenberg M, Zaganjor E,
Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM,
Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death
involving voltage-dependent anion channels. Nature. 447:864–868.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ponde NF, Zardavas D and Piccart M:
Progress in adjuvant systemic therapy for breast cancer. Nat Rev
Clin Oncol. 16:27–44. 2019. View Article : Google Scholar
|
